Cerity Partners LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cerity Partners LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$339,017
-6.8%
21,886
-4.1%
0.00%0.0%
Q1 2024$363,846
+25.6%
22,826
+32.5%
0.00%0.0%
Q4 2023$289,653
+60.4%
17,231
+11.5%
0.00%0.0%
Q3 2023$180,623
-58.6%
15,451
+2689.0%
0.00%0.0%
Q1 2023$436,6045540.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Broadfin Capital, LLC 7,097,300$27,750,0004.54%
GREAT POINT PARTNERS LLC 3,817,288$14,926,0002.55%
TANAKA CAPITAL MANAGEMENT INC 256,593$1,003,0002.29%
Consonance Capital Management LP 4,473,607$17,492,0001.58%
Avoro Capital Advisors LLC 3,892,343$15,219,0000.99%
KNOTT DAVID M 380,110$1,486,0000.59%
EAM Investors, LLC 790,872$3,092,0000.55%
Ghost Tree Capital, LLC 550,000$2,151,0000.50%
EAM Global Investors LLC 251,647$984,0000.50%
MANGROVE PARTNERS IM, LLC 924,648$3,615,0000.49%
View complete list of CATALYST PHARMACEUTICALS INC shareholders